Alchemi
Alchemi's AI platform speeds regulated drug development by automating reporting and streamlining QC/QA for laboratory assays. It ingests assay files, transforms them into regulatory-compliant documents, flags guideline compliance, and integrates with LIMS and ELN systems. Delivered as a SaaS platform built for GxP environments, it implements AI designed for FDA 21 CFR Part 11 compliance, SOC 2 security, and zero data retention by models. Typical customers are pharmaceutical and biotech R&D teams using the platform across CMC, bioanalysis, clinical development, and regulatory submissions to reduce manual transcription and accelerate study timelines.
Alchemi
Alchemi's AI platform speeds regulated drug development by automating reporting and streamlining QC/QA for laboratory assays. It ingests assay files, transforms them into regulatory-compliant documents, flags guideline compliance, and integrates with LIMS and ELN systems. Delivered as a SaaS platform built for GxP environments, it implements AI designed for FDA 21 CFR Part 11 compliance, SOC 2 security, and zero data retention by models. Typical customers are pharmaceutical and biotech R&D teams using the platform across CMC, bioanalysis, clinical development, and regulatory submissions to reduce manual transcription and accelerate study timelines.
TL;DR
What they do: SaaS AI platform that automates reporting and QC/QA for regulated drug-development assays (GxP/21 CFR Part 11 focus)
Customers: Pharmaceutical and biotech R&D teams across CMC, bioanalysis, clinical development, and regulatory submissions
Founders: Anuj Chadha and Tom Mulvey
Stage / funding: Seed-stage; disclosed investors include Flybridge and Nebular
Company Overview
Problem Domain
Automation and compliance for regulated drug-development laboratory workflows (assay reporting, QC/QA, regulatory submissions).
Founded
2024
Industry
DeepTech
Tech Stack
Funding Track Record
3300000
Investors include Flybridge, Maple VC, and Nebular (per disclosed summaries)
Investor Signal
“Investors include Flybridge, Maple VC, and Nebular”